Effect of whole body vertical vibration technique on autonomic nerve in healthy subjects

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026967

Enrollment

Unknown

Registered

2019-10-27

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not

Interventions

Blank control group:Giving whole body vertical vibration therapy with frequency of 0HZ

Positive control group:Giving whole body vertical vibration therapy with frequency of 15HZ

Negative control group:Giving whole body vertical vibration therapy with frequency of 25HZ

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18-28 years old in good health; 2. better compliance; 3. sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Subjects were equipped with cardiac pacemaker or severe cardiopulmonary disease; 2. Cognitive impairment; 3. Vital signs unstable, fever; 4. Recent soft tissue injury, fracture and recent implantation of metal foreign bodies in the body; 5. Patients with history of epilepsy and family history of epilepsy; 6. Soft tissue injury, fracture, disc herniation and spondylolisthesis acute stage or rheumatoid arthritis; 7. Taking or injecting drugs affecting the relevant indexes of the experiment before the experiment; 8. There are obvious contraindications of whole body vertical vibration therapy.

Design outcomes

Primary

Measure	Time frame
blood pressure;Heart rate;	—

Countries

China

Contacts

Public ContactShan-Min Xie, Hui-Li, Jing-LI Liang

Guangdong General Hospital

2034216967@qq.com+86 15917380958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026